| abstract |
WHICH INCLUDES: a) 0.005% TO 5% OF THE TOTAL WEIGHT OF A SELECTED OPHTHALMIC DRUG FROM: DICLOFENAC, PREDNISOLONE, KETOTYPHENE, ASCORBIC ACID, RETINAL, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEM; b) 0.05% TO 10% OF A LINEAR POLYSACCHARIDE COMPOUND SUCH AS SODIUM HYALURONATE; AT LEAST ONE OF THE FOLLOWING COMPONENTS: c) TONICITY IMPROVING AGENT; d) pH REGULATOR; e) CONSERVATIVE SUCH AS BENZALCONIUM CHLORIDE; f) A REACTION PRODUCT OF NATURAL OILS OR HYDROGENES AND ETHYLENE GLYCOL AS A SOLUBILIZER, IN PARTICULAR OCTILPHENOXY-POLY (ETHYLENOXY) ETHANOL; g) COMPLEX FORMING AGENT; AND / OR h) OPHTHALMIC VEHICLE. WHERE, THE VISCOSITY OF THE COMPOSITION IS FROM 500 mPa TO 2 000 mPa BETWEEN 20 ° C AND 25 ° C, WHICH IS APPLICABLE IN THE TREATMENT OF OPHTHALMIC DISEASES / DISORDERS SUCH AS: GLAUCOMA, MIOSIS, ANESTHESIA OR INFECTIONS CAUSED BY VIRUSES; AS WELL AS IN THE PREVENTION AND TREATMENT OF ALLERGIC CONJUNCTIVITIS |